Printer Friendly
The Free Library
14,814,956 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Matria Healthcare Reports Second Quarter Results That Exceed Earnings Guidance.


MARIETTA Marietta (mârēĕt`ə).

1 City (1990 pop. 44,129), seat of Cobb co., NW Ga.; inc. 1834. The principal manufactures of this suburb of Atlanta are related to aircraft production. At the foot of Kennesaw Mt.
, Ga. -- -Matria Healthcare, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: MATR MATR Montana Associated Technology Roundtables
Matr Matroos (Dutch)
MATR Minimum Average Time Requirement
) today announced its financial results for the second quarter and six months ended June June: see month.  30, 2006.

For all periods presented in this press release, Matria's continuing operations continuing operations

Parts of a business that are expected to be maintained as an ongoing segment of an overall business operation. Income and losses from continuing operations are reported separately if any segments have been discontinued during the
 include the Company's disease management, wellness and productivity enhancement, and maternity MATERNITY. The state or condition of a mother.
     2. It is either legitimate or natural. The former is the condition of the mother who has given birth to legitimate children, while the latter is the condition of her who has given birth to illegitimate children.
 management businesses that are reported in the Company's Health Enhancement segment. Included in discontinued operations Discontinued operations

Divisions of a business that have been sold or written off and that no longer are maintained by the business.
 are Facet Technologies and Dia Real, which are classified as assets held for sale.

Revenues for the second quarter of 2006 were $82.6 million, compared with $44.8 million in the second quarter of 2005. Before share-based compensation expense, operating profits Operating profit (or loss)

Revenue from a firm's regular activities less costs and expenses and before income deductions.


operating profit

See operating income.
 from continuing operations for the second quarter of 2006 were $16.3 million, or 20% of net revenue, compared to $1.9 million, or 4% of net revenue, reported in the second quarter of 2005. The Company began expensing share-based compensation January January: see month.  1, 2006. After share-based compensation expense of $1.8 million, operating profits from continuing operations for the second quarter of 2006 were $14.5 million, or 18% of net revenue.

Earnings from continuing operations for the second quarter of 2006 were $6.1 million, or $0.28 per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 common share, before share-based compensation expense of $0.06 per diluted common share, compared with $0.8 million, or $0.04 per diluted common share, in the 2005 second quarter. Earnings before interest, taxes, depreciation and amortization Earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP metric that can be used to evaluate a company's profitability.
:EBITDA = Operating Revenue – Operating Expenses + Other Revenue
 (EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become ) for the second quarter of 2006 were $21.3 million, compared to $3.4 million in second quarter 2005, in each case excluding share-based compensation.

The Company's second quarter of 2006 disease management and wellness revenues were $55.7 million, compared to $18.5 million in the second quarter of 2005. Maternity management revenues for the second quarter of 2006 increased by 3% to $27 million, compared to $26.2 million in the 2005 second quarter.

Parker H. Petit PETIT, sometimes corrupted into petty. A French word signifying little, small. It is frequently used, as petit larceny, petit jury, petit treason.

PETIT, TREASON, English law. The killing of a master by his servant; a husband by his wife; a superior by a secular or religious man.
, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "It has been six months since we started our integration initiatives involving CorSolutions. We are pleased with our achievements to date. Our corporate functions, clinical operations and sales force have been fully integrated, and we are now realizing the very positive impact of our integration efforts on our profit margins. Our strategy was to complete our integration initiatives expeditiously ex·pe·di·tious  
adj.
Acting or done with speed and efficiency. See Synonyms at fast1.



ex
 so the anticipated profit improvements and synergies could be realized quickly. We have successfully achieved that goal. Now, with that milestone “Milemarker” redirects here. For the American indie rock band, see Milemarker (band).

A milestone or kilometre sign is one of a series of numbered markers placed along a road at regular intervals, typically at the side of the road or in a median.
 behind us, we should begin to show stronger growth in revenues."

Revenues for the six months ended June 30, 2006, were $163.5 million, compared with $84.4 million for the first six months of 2005. Before share-based compensation expense, operating profits from continuing operations for the six months ended June 30, 2006, were $29.8 million, compared with $3.2 million for the same period in 2005. After share-based compensation expense of $3.2 million, operating profits for the first six months of 2006 were $26.5 million. Earnings from continuing operations for the first six months of 2006 were $10.5 million, or $0.49 per diluted common share, before share-based compensation expense of $0.11 per diluted common share, compared with $0.9 million, or $0.05 per diluted common share, for the 2005 same period. EBITDA for the six months ended June 30, 2006, was $39.2 million, excluding share-based compensation of $3.2 million.

Disease management and wellness revenues for the first six months of 2006 were $111.2 million, compared with $34.0 million in 2005. Maternity management revenues for the first six months of 2006 increased by 4% to $52.4 million, compared with $50.4 million in 2005.

DIVESTITURE The breakup of AT&T. By federal court order, AT&T divested itself on January 1, 1984 of its 23 operating companies, which became known as the Regional Bell Operating Companies (RBOCs).  AND DEBT REDUCTION

Earlier today, Matria announced that it had signed a definitive agreement to sell Facet Technologies to a new company formed by Water Street Capital Partners, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
., a Chicago-based private equity firm specializing in healthcare investments. "We have entertained en·ter·tain  
v. en·ter·tained, en·ter·tain·ing, en·ter·tains

v.tr.
1. To hold the attention of with something amusing or diverting. See Synonyms at amuse.

2.
 bids from a number of suitors and have selected an excellent successor to lead Facet. The definitive agreement for the sale of Facet marks a significant accomplishment in our strategy to become a pure play in the disease management sector of healthcare. The transaction is expected to significantly reduce our outstanding indebtedness INDEBTEDNESS. The state, of being in debt, without regard to the ability or inability of the party to pay the same. See 1 Story, Eq. 343; 2 Hill. Ab. 421.
     2.
," commented Petit.

Based on the expected proceeds from the Facet and Dia Real divestitures and expected operating cash flows Operating cash flow

Earnings before depreciation minus taxes. Measures the cash generated from operations, not counting capital spending or working capital requirements.
, the Company anticipates reducing outstanding indebtedness by approximately ap·prox·i·mate  
adj.
1. Almost exact or correct: the approximate time of the accident.

2.
 $175 million this year. Subsequent to the end of the second quarter, the Company used its operating cash flow to make its first debt pre-payment in the amount of $10 million.

Interest expense, net of interest income for the second half of the year, is expected to be approximately $13 million to $14 million. This projection projection, in psychology: see defense mechanism.


See rear-projection TV, front-projection TV and LCD panel.

(theory) projection - In domain theory, a function, f, which is (a) idempotent, i.e.
 for the second half of the year reflects the Company's current expectations of net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 from Facet and Dia Real, an increase in interest rates for the portion of debt not fixed by swap agreements and anticipated future debt pre-payments from operating cash flow.

THIRD QUARTER AND FULL YEAR GUIDANCE

Matria announced its third quarter 2006 revenue guidance to be between $83 million and $85 million. The Company expects third quarter operating profits from continuing operations to range from $16 million to $17 million, EBITDA from continuing operations to be between $21 million and $22 million, and earnings per diluted common share from continuing operations to be in the range of $0.26 to $0.28, in all cases excluding share-based compensation expense of $0.06 to $0.07 per diluted common share.

The Company also reaffirmed its full year 2006 guidance of revenue expectations to be between $337 million and $341 million. The Company expects full year 2006 operating profits from continuing operations to range from $65 million to $68 million, EBITDA from continuing operations to be between $82 million and $86 million, and earnings per diluted common share from continuing operations to be in the range of $1.10 to $1.17, in all cases excluding share-based compensation expense of $0.23 to $0.27 per diluted common share.

As of today, new business awards that are expected to begin producing revenue in 2007 represents $5.8 million of annualized annualized

Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared.
 revenue, with most of the awards commencing in January. Consistent with past practice, Matria will provide its 2007 guidance in December December: see month.  2006.

A listen-only simulcast Simulcast is a portmanteau of "simultaneous broadcast", and refers to programs or events broadcast across more than one medium, or more than one service on the same medium, at the same time.  and replay of Matria Healthcare's second quarter conference call will be available on-line at the Company's website at www.matria.com or at www.fulldisclosure.com on July July: see month.  27, 2006, beginning at 9:00 a.m. Eastern time.

ABOUT MATRIA HEALTHCARE

Matria Healthcare is a leading provider of comprehensive health enhancement programs to health plans, employers and government agencies. Matria manages major chronic diseases and episodic episodic

sporadic; occurring in episodes. e. falling a paroxymal disorder described in Cavalier King Charles spaniels in which affected dogs, starting at an early age, experience episodes of extensor rigidity, possibly brought on by stress. e.
 conditions including diabetes diabetes or diabetes mellitus (məlī`təs), chronic disorder of glucose (sugar) metabolism caused by inadequate production or use of insulin, a hormone produced in specialized cells (beta cells in the islets of , congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. , coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , asthma asthma (ăz`mə, ăs`–), chronic inflammatory respiratory disease characterized by periodic attacks of wheezing, shortness of breath, and a tight feeling in the chest. A cough producing sticky mucus is symptomatic. , chronic obstructive pulmonary disease chronic obstructive pulmonary disease
n. Abbr. COPD
A chronic lung disease, such as asthma or emphysema, in which breathing becomes slowed or forced.
, high-risk high-risk adjective Referring to an ↑ risk of suffering from a particular condition Infectious disease Referring to an ↑ risk for exposure to blood-borne pathogens, which occurs with blood bank technicians, dental professionals, dialysis unit  obstetrics obstetrics (ŏbstĕ`trĭks), branch of medicine concerned with the treatment of women during pregnancy, labor, childbirth (see birth), and the time after childbirth. , cancer, chronic pain, depression, end-stage renal disease End-stage renal disease (ESRD)
Total kidney failure; chronic kidney failure is diagnosed as ESRD when kidney function falls to 5-10% of capacity.

Mentioned in: Chronic Kidney Failure

end-stage renal disease 
, and obesity obesity, condition resulting from excessive storage of fat in the body. Obesity has been defined as a weight more than 20% above what is considered normal according to standard age, height, and weight tables, or by a complex formula known as the body mass index. ; delivers programs that address wellness, healthy living, productivity improvement, and patient advocacy Patient advocacy refers to speaking on behalf of a patient in order to protect their rights and help them obtain needed information and services. The role of patient advocate is frequently assumed by nurses, social workers, and other healthcare providers. ; and provides case management of acute and catastrophic conditions. Headquartered in Marietta, Georgia Marietta is a city located in central Cobb County, Georgia GR6, and is its county seat.

As of the 2000 census, the city had a total population of 58,748, making it one of metro Atlanta's largest suburbs.
, Matria operates through more than 50 offices around the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . More information about Matria can be found on line at www.matria.com.

SAFE HARBOR Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 STATEMENT

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. Such statements include but are not limited to the Company's financial expectations for the third quarter and full year 2006, annualized revenues from awards expected to begin producing revenue in 2007, the success of the integration of CorSolutions, the synergies resulting from the integration of CorSolutions and the impact on the Company's profit margins, the Company's expectations for stronger revenue growth, the consummation CONSUMMATION. The completion of a thing; as the consummation of marriage; (q.v.) the consummation of a contract, and the like.
     2. A contract is said to be consummated, when everything to be done in relation to it, has been accomplished.
 of the sale of Facet Technologies and potential sale of Dia Real, the timing thereof, the validity of the Company's interest rate assumptions, and the amount of the Company's expected debt repayments. These statements are based on current information and belief, and are not guarantees of future performance. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include the Company's inability to achieve its financial expectations, failure to realize anticipated revenues from backlog Backlog

The total value of sales orders waiting to be fulfilled.

Notes:
This figure is used mainly in the manufacturing industry. Increases or decreases in a company's backlog indicate the future direction of sales and earnings.
, additional integration issues, failure to achieve anticipated synergies, lower than anticipated profit margins, failure to achieve expected revenue growth, failure to consummate To carry into completion; to fulfill; to accomplish.

A Common-Law Marriage is consummated when the parties live in a manner intended to bring about public recognition of their relationship as Husband and Wife.
 the sale of Facet Technologies, failure to consummate a sale of Dia Real, delays in sales of either of these businesses or sales on terms less favorable fa·vor·a·ble  
adj.
1. Advantageous; helpful: favorable winds.

2. Encouraging; propitious: a favorable diagnosis.

3.
 than currently anticipated, reduced cash flows from operations, unanticipated uses of cash, higher than expected interest rates, developments in the healthcare industry, third-party actions over which Matria does not have control, regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country.  applicable to Matria's business and the risk factors detailed from time to time in Matria's periodic reports and registration statements filed with the Securities and Exchange Commission, including Matria's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2005. By making these forward-looking statements, Matria does not undertake to update them in any manner except as may be required by Matria's disclosure obligations in filings it makes with the Securities and Exchange Commission under the federal securities laws.
Matria Healthcare, Inc.
      Unaudited Consolidated Condensed Statements of Operations
           (Amounts in thousands, except per share amounts)

                                Three Months Ended   Six Months Ended
                                     June 30,            June 30,
                               -------------------- ------------------
                                  2006      2005      2006     2005
                               ----------- -------- --------- --------

Revenues                          $82,627  $44,762  $163,533  $84,385

Cost of revenues                   26,590   18,165    52,861   33,936
Selling and administrative
 expenses                          39,769   24,672    80,582   47,226
Amortization of intangible
 assets                             1,786       40     3,572       40
                               ----------- -------- --------- --------

  Operating earnings from
   continuing Operations           14,482    1,885    26,518    3,183
Interest expense, net              (6,639)    (641)  (12,832)  (1,648)
Other income (expense), net           464       27       569      (19)
                               ----------- -------- --------- --------
   Earnings from continuing
    operations before income
    taxes                           8,307    1,271    14,255    1,516
Income tax expense                 (3,473)    (515)   (6,005)    (614)
                               ----------- -------- --------- --------
   Earnings from continuing
    operations                      4,834      756     8,250      902
   Earnings from discontinued
    operations, net of tax          2,391    4,318     3,898    7,978
                               ----------- -------- --------- --------
Net earnings                       $7,225   $5,074   $12,148   $8,880
                               =========== ======== ========= ========

Net earnings per common share:
     Basic
        Continuing Operations       $0.23    $0.04     $0.39    $0.05
        Discontinued Operations      0.11     0.25      0.19     0.48
                               ----------- -------- --------- --------
                                    $0.34    $0.29     $0.58    $0.53
                               =========== ======== ========= ========
     Diluted
        Continuing Operations       $0.22    $0.04     $0.38    $0.05
        Discontinued Operations      0.11     0.23      0.18     0.45
                               =========== ======== ========= ========
                                    $0.33    $0.27     $0.56    $0.50
                               =========== ======== ========= ========

Weighted average shares
 outstanding:
       Basic                       20,970   17,775    20,916   16,867
                               =========== ======== ========= ========
       Diluted                     21,574   18,776    21,660   17,907
                               =========== ======== ========= ========



                       Matria Healthcare, Inc.
           Unaudited Consolidated Condensed Balance Sheets
                        (Amounts in thousands)


                                           June 30,     December 31,
                                              2006          2005
                                          -----------  ---------------
ASSETS
------
Current assets:
      Cash and cash equivalents              $23,259          $22,758
      Restricted cash                          1,594              550
      Trade accounts receivable, net          52,587           33,996
      Assets held for sale                   135,649          132,455
      Prepaid expenses and other current
       assets                                 11,233            6,588
    Deferred income taxes                     13,720            8,629
                                          -----------  ---------------
             Total current assets            238,042          204,976

Property and equipment, net                   37,508           26,430
Goodwill, net                                456,450           69,248
Other intangibles, net                        59,463            6,935
Deferred income taxes                         12,787           10,666
Other assets                                  14,631            4,952
                                          -----------  ---------------
                                            $818,881         $323,207
                                          ===========  ===============

LIABILITIES AND SHAREHOLDERS' EQUITY
------------------------------------
Current liabilities:

     Current installments of long-term
      debt and obligations under capital
      leases                                $177,342           $1,021
     Accounts payable, principally trade       9,501           10,702
     Liabilities related to assets held
      for sale and other discontinued
      operations                              22,202           31,042
      Unearned revenue                        16,307            7,205
     Other accrued liabilities                32,133           13,412
                                          -----------  ---------------
          Total current liabilities          257,485           63,382


Long-term debt and obligations under
 capital leases, excluding current
installments                                 279,709            2,099
Other long-term liabilities                   10,382            5,788
                                          -----------  ---------------
      Total liabilities                      547,576           71,269

Shareholders' equity                         271,305          251,938
                                          -----------  ---------------
                                            $818,881         $323,207
                                          ===========  ===============


                        Matria Healthcare, Inc.
        Unaudited Reconciliation of Non-GAAP Financial Measures
           (Amounts in thousands, except per share amounts)

                                         Three Months      Six Months
                                            Ended            Ended
                                           June 30,         June 30,
                                      ---------------   ------------
                                        2006    2005     2006    2005
                                      -------  ------  -------  ------

Reconciliation of Operating Earnings
 from Continuing Operations As
 Reported to Operating Earnings from
 Continuing Operations Excluding
 Share-Based Compensation
------------------------------------

Operating earnings from continuing
 operations as reported              $14,482  $1,885  $26,518  $3,183

Add share-based compensation           1,797       -    3,248       -
                                      ------- -------  ------- -------
    Operating earnings from
     continuing operations excluding
     share-based compensation        $16,279  $1,885  $29,766  $3,183
                                      -------  ------  -------  ------

Reconciliation of Earnings from
 Continuing Operations As Reported
 to Earnings from Continuing
 Operations Excluding Share-Based
 Compensation
------------------------------------

Earnings from continuing operations
 as reported                         $ 4,834  $  756  $ 8,250  $  902
                                          --                -
Add share-based compensation, net of
 tax                                   1,254       -    2,295       -
                                      ------- -------  ------- -------
    Earnings from continuing
     operations excluding share-
     based compensation              $ 6,088  $  756  $10,545  $  902
                                      -------  ------  -------  ------

Reconciliation of Earnings from
 Continuing Operations to EBITDA
 from Continuing Operations
 Excluding Share-Based Compensation
------------------------------------

Earnings from continuing operations  $ 4,834  $  756  $ 8,250  $  902

Interest expense, net                  6,639     641   12,832   1,648

Income tax expense                     3,473     515    6,005     614

Depreciation and amortization          4,513   1,529    8,886   2,898

Share-based compensation               1,797       -    3,248       -
                                      ------- -------  ------- -------
     EBITDA excluding share-based
      compensation                   $21,256  $3,441  $39,221  $6,062
                                      -------  ------  -------  ------

Reconciliation of Diluted Earnings
 Per Common Share from Continuing
 Operations As Reported to Diluted
 Earnings Per Common Share from
 Continuing Operations Excluding
 Share-Based Compensation
------------------------------------

Diluted earnings per common share as
 reported                            $  0.22  $ 0.04  $  0.38  $ 0.05

Add share-based compensation, net of
 tax                                    0.06       -     0.11       -
                                      ------- -------  ------- -------
   Diluted earnings per common share
    excluding share-based
    compensation                     $  0.28  $ 0.04  $  0.49  $ 0.05
                                      =======  ======  =======  ======



                       Matria Healthcare, Inc.
   Reconciliation of Non-GAAP Financial Measures for 2006 Guidance
           (Amounts in millions, except per share amounts)

                                        Q3 2006           YR 2006
                                    ----------------   ---------------
Reconciliation of Operating Profit
 from Continuing Operations to
 Operating Profit from Continuing
 Operations Excluding Share-Based
 Compensation                          Low     High       Low    High
---------------------------------  ---------- ------   -------- ------
Operating profit from continuing
 operations                              $14    $15        $57    $61
Share-based compensation                   2      2          8      7
                                    --------- ------   -------- ------
Operating profit from continuing
 operations excluding share-based
 compensation                            $16    $17        $65    $68
                                    ========= ======   ======== ======


Reconciliation of Earnings from
 Continuing Operations to EBITDA
 from Continuing Operations
 Excluding Share-Based Compensation    Low     High      Low     High
-----------------------------------  -------- ------   -------- ------
Earnings from continuing operations       $4     $5        $18    $20
Share-based compensation                   2      2          8      7
Income tax expense                         3      3         12     15
Interest expense, net                      7      7         26     26
Depreciation and amortization              5      5         18     18
                                    --------- ------   -------- ------
EBITDA excluding share-based
 compensation                            $21    $22        $82    $86
                                    ========= ======   ======== ======

Reconciliation of Earnings Per
 Diluted Share from Continuing
 Operations to Earnings Per Diluted
 Share from Continuing Operations
 Excluding Share-Based Compensation    Low     High      Low     High
----------------------------------- --------- ------   -------- ------
Earnings per diluted share from
 continuing operations                 $0.19  $0.22      $0.83  $0.94
Share-based compensation                0.07   0.06       0.27   0.23
                                    --------- ------   -------- ------
Earnings per diluted share from
 continuing operations excluding
 share-based compensation              $0.26  $0.28      $1.10  $1.17
                                    ========= ======   ======== ======


                       Acquisition Debt Summary
                      June 30, 2006 ($ Thousands)

                                  Balance        Rate Basis     Rate
First Lien:

Tranche B
   Fixed (SWAP)                     $100,000    LIBOR + 225     7.32%
   Fixed (SWAP)                     $100,000    LIBOR + 225     7.60%
   Floating                          $63,700    LIBOR + 225     7.75%
Tranche C                           $125,000    LIBOR + 225     7.75%

Second Lien                          $65,000    LIBOR + 675    12.25%
                              ---------------
Total Loan outstanding              $453,700

COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 27, 2006
Words:2490
Previous Article:Scholastic Corrects Share Count, Resulting in Fiscal 2006 EPS Reduction of $0.03; No Change to Other Financial Results.
Next Article:SkyTerra Communications, Inc. Announces Results of Stockholders Meeting and Redemption of Preferred Stock Through Completion of Rights Offering.
Topics:



Related Articles
Reversals of Fortune: Sewing Up Splits.(AMRESCO's market value)(Brief Article)
Matria Healthcare's First Quarter Results Exceed Expectations; Company Reports Record Revenues for the Quarter.
Matria Announces Proposed Tender Offer and Consent Solicitation for 11% Senior Notes Due 2008, Revises Profit Expectations for the First Quarter and...
Matria Healthcare Announces Revenue Growth of 13% for the First Quarter 2004; Company Reports EPS of $0.09 for the First Quarter of 2004.
Matria Healthcare Announces Agreement to Sell Pharmacy and Supplies Business.
Matria's Second Quarter Profits to Exceed High End Guidance and Securities Litigation Dismissed.
Matria Healthcare Expects to Exceed Third Quarter Earnings Estimates; Company Awarded Five New Disease Management Accounts.
Reporting; Sarbanes-Oxley effect: caution on guidance.(influence on corporate fraud)(Brief Article)
Matria Successfully Refinances $65 Million Second Lien Facility.
Matria Healthcare Reports Third Quarter Results.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles